The U.S. Food and Drug Administration (FDA) has granted authorization to Juul Labs for the sale of its e-cigarette device and tobacco and menthol-flavored refill cartridges in the United States. This decision comes after a prolonged period of regulatory scrutiny and legal challenges for Juul, which had faced a federal ban in 2022 that was later stayed and rescinded. The authorization specifically covers cartridges in both 3% and 5% nicotine strengths, while sweet and fruity flavors remain off the market.
This FDA approval provides a crucial lifeline for Juul, a company that was once a dominant player in the e-cigarette market but saw its fortunes decline amidst accusations of marketing to teenagers and subsequent lawsuits. The company, which at one point was valued at over $13 billion, nearly filed for bankruptcy. The FDA stated that Juul's studies demonstrated its e-cigarettes are less harmful for adult smokers who completely switch to vaping, justifying the authorization under public health protection rules.
Juul will now be one of only two U.S. companies permitted to sell menthol-flavored vapes, a significant market segment preferred by many adult users. The FDA has authorized a total of 39 e-cigarette products for sale since it began regulating such devices in August 2016. This decision effectively ends a lengthy standoff with regulators and lawmakers who previously criticized Juul for its role in the surge of youth e-cigarette use.
